Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04786964
Title Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab (CK-301) in First Line Metastatic Non-squamous Non-Small Cell Lung Cancer (CONTERNO)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Checkpoint Therapeutics, Inc.

lung non-squamous non-small cell carcinoma


Carboplatin + Pemetrexed Disodium

Cisplatin + Pemetrexed Disodium

Cisplatin + Cosibelimab + Pemetrexed Disodium

Carboplatin + Cosibelimab + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries

No variant requirements are available.